1. Laganowski HC, Kerr Muir MG, Hitchings RA. Glaucoma and the iridocorneal endothelial syndrome. Arch Ophthalmol. 1992. 110:346–350.
2. Kidd M, Hetherington J, Magee S. Surgical results in iridocorneal endothelial syndrome. Arch Ophthalmol. 1988. 106:199–201.
3. Shields MB, Campbell DG, Simmons RJ. The essential iris atrophies. Am J Ophthalmol. 1978. 85:749–759.
4. Patel A, Kenyon KR, Hirst LW, et al. Clinicopathologic features of Chandler's syndrome. Surv Ophthalmol. 1983. 27:327–344.
5. Hetherington J Jr. The spectrum of Chandler's syndrome. Ophthalmology. 1978. 85:240–244.
6. Scheie HG, Yanoff M. Iris nevus (Cogan-Reese) syndrome. A cause of unilateral glaucoma. Arch Ophthalmol. 1975. 93:963–970.
7. Rodrigues MM, Streeten BW, Spaeth GL. Chandler's syndrome as a variant of essential iris atrophy. A clinicopathologic study. Arch Ophthalmol. 1978. 96:643–652.
8. Boberg-Ans J. Essential progressive iris atrophy. Br J Ophthalmol. 1969. 53:649–651.
9. Wright MM, Grajewski AL, Cristol SM, Parrish RK. 5-Fluorouracil after trabeculectomy and the iridocorneal endothelial syndrome. Ophthalmology. 1991. 98:314–316.
10. Lanzl IM, Wilson RP, Dudley D, et al. Outcome of trabeculectomy with mitomycin-C in the iridocorneal endothelial syndrome. Ophthalmology. 2000. 107:295–297.
11. Kim DK, Aslanides IM, Schmidt CM Jr, et al. Long-term outcome of aqueous shunt surgery in ten patients with iridocorneal endothelial syndrome. Ophthalmology. 1999. 106:1030–1034.
12. Doe EA, Budenz DL, Gedde SJ, Imami NR. Long-term surgical outcomes of patients with glaucoma secondary to the iridocorneal endothelial syndrome. Ophthalmology. 2001. 108:1789–1795.
13. Kim CS, Yim JH, Lee EK, Lee NH. Changes in corneal endothelial cell density and morphology after Ahmed glaucoma valve implantation during the first year of follow up. Clin Experiment Ophthalmol. 2008. 36:142–147.
14. Fiore PM, Richter CU, Arzeno G, et al. The effect of anterior chamber depth on endothelial cell count after filtration surgery. Arch Ophthalmol. 1989. 107:1609–1611.